WHO report highlights the role of Traditional Chinese Medicine in the treatment of COVID-19

BEIJING, April 18, 2022 /PRNewswire/ — A news report by haiwainet.cn: On March 31, World Health Organization released the meeting report of “WHO Expert Meeting on Evaluation of Traditional Chinese Medicine (TCM) in the Treatment of COVID-19” on its official website. The report acknowledged that on the basis of clinically relevant outcome measures, the studied […]

BEIJING, April 18, 2022 /PRNewswire/ — A news report by haiwainet.cn:

On March 31, World Health Organization released the meeting report of “WHO Expert Meeting on Evaluation of Traditional Chinese Medicine (TCM) in the Treatment of COVID-19” on its official website. The report acknowledged that on the basis of clinically relevant outcome measures, the studied TCMs are beneficial in the treatment of COVID-19, particularly in mild-to-moderate cases. WHO encourages Member States to consider the integration of traditional medicine interventions such as TCM in planning for the clinical management of COVID-19 in the context of their healthcare systems and regulatory frameworks.

The report pointed out that in the process of treating COVID-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe COVID-19. When administered as add-on interventions to conventional treatment, TCM may shorten the time for viral clearance, resolution of clinical symptoms, and length of hospital stay when compared to conventional treatment alone.

The report recommends that WHO should share the outcomes of this consultation with Member States in a timely manner given the evolving nature of COVID-19 globally. Member States are encouraged to consider the potential use of TCM for the management of COVID-19 in the context of their healthcare systems and regulatory frameworks; share experiences and lessons, particularly those actively acquired through this organized research programme in TCM and clinical experience from China.

Yu Wenming, head of China’s National Administration of Traditional Chinese Medicine, said China is willing to assist other WHO Member States to strengthen the role of traditional medicine in their health systems.

As of March 2022, the Chinese Clinical Trials Registry, which is part of WHO’s ICTRP (International Clinical Trials Registry Platform), showed 859 clinical studies of COVID-19 in China. Among these Chinese clinical trials, 213 relate to TCM.

Total
0
Shares
Previous Article

‫شركة هندسة تكنولوجيا المعلومات اليابانية DS Technologies من مجموعة DSK تختار التطبيق الأول لـ NewNet في الصناعة “STC” لنشر خدمات الدفع الخاصة بهم

Next Article

‫ عرض شركة Changhong الصينية المصنِّعة للأجهزة المنزلية، لمجموعة كاملة من المنتجات في النسخة 131 من معرض كانتون الذي سيعقد على الإنترنيت

Related Posts

‫شبكة تلفزيون الصين الدولية (‏CGTN): نظرة إلى الوراء في عام 2021: تحقيق الأحلام الصينية

بكين، 21 سبتمبر، 2021 /PRNewswire/ – مهرجان منتصف الخريف الصيني، الذي يُحتفل به في 21 سبتمبر من هذا العام، هو مناسبة للم شمل الأسرة. إنه يوم يعتقد فيه الكثير من الناس أن الأحلام تتحقق عندما يكون القمر في أقصى درجاته. في هذا اليوم، دعونا نلقي نظرة على عام 2021، والذي شهد حتى الآن تحقيق العديد […]

Sphera Named a Market Leader for Carbon Management Software in Independent Research Report

Sphera’s ESG software was recognized in inaugural report on enterprise carbon management solutions by independent analyst firm CHICAGO, Aug. 02, 2022 (GLOBE NEWSWIRE) — Sphera®, a leading global provider of Environmental, Social and Governance (ESG) performance and risk management software, data and consulting services, has been named a leader in the carbon management software market by […]